Mediwhale News
Read more about our recent AI diagnostic solution and ongoing innovations.
Mediwhale to unveil AI tech predicting cardiovascular diseases at AHA 2024
Korea Biomedical Reviewㅣ 2024-11-15 Medical AI company Mediwhale will release three research abstracts on its AI-powered cardiovascular disease (CVD) prediction software, Reti-CVD, at the American Heart Association’s (AHA) Scientific Sessions 2024, which will be held...
Mediwhale wins 1st place in MICCAI’s medical AI competition
Korea Biomedical Reviewㅣ 2024-10-30 Mediwhale said Wednesday that it has won first place in two categories at the Medical AI Competition organized by the Medical Image Computing and Computer Assisted Intervention (MICCAI). MICCAI is the most prestigious conference in...
Tyler Hyung-taek Rim, Chief Medical Officer of Mediwhale, named ‘Top 2% Scientist in the World’ for two consecutive years
The BIOㅣ 2024-10-10 - Academic information analysis Stanford/Elsevier assess research capabilities: Recognition for innovation in ‘retina-based disease prediction’ research - Global medical community takes notice of DrNoon: The world’s first AI for predicting...
CEO explains how Mediwhale’s AI-backed retinal scanning predicts cardiovascular disease risk
Korea Biomedical Reviewㅣ 2024-09-04 For 25 years, Choi Tae-geun, CEO of the Korean medical AI company Mediwhale, lived under the illusion of perfect health. But just before turning 26, a routine eye exam with Professor Rim Hyung-taek, who currently serves as the...
Mediwhale Secures $12 Million in Series A2 Funding to Drive Global Leadership in Cardiovascular and Metabolic Disease Management
APㅣ Sep. 26 2024 SEOUL, South Korea, Sept. 25, 2024 /PRNewswire/ -- Mediwhale, the AI-powered health diagnostics company, announced $12 million series A2 investments. This funding leverages the momentum of their technological advancements and rapid adoption of its...
Mediwhale picked as J&J Innovation-supported ‘JLABS’ firm
Korea Biomedical Review | 2024-06-27 Mediwhale, a medical AI diagnostic solution provider, said Thursday that it has been selected as a “JLABS” company, benefitting from a global accelerator platform operated by Johnson & Johnson Innovation, a multinational...
Retinal Imaging, Algorithm Predicts Cardiovascular Disease Events
MDalert | November, 2023 A deep learning algorithm that utilizes retinal images, Reti-CVD predicts cardiovascular disease (CVD) events in prediabetic and diabetic patients, according to research presented at the AHA Scientific Sessions 2023 in Philadelphia. Tyler...
Mediwhale: This Innovative AI-Powered Health Diagnostics Company Uses Non-Invasive Retina Scans To Prevent Diseases
Pulse 2.0 | Septemeber 21, 2023 Mediwhale is an AI-empowered health diagnostics company that uses non-invasive retina scans to help prevent heart and kidney diseases. And Mediwhale’s Reti-Intelligence suite of services uses deep learning algorithms to detect disease...
AI Using Retina Scan Improves Kidney Disease Prediction
Specialty Pharmacy Continuum | August 18, 2023 An artificial intelligence tool combined with a noninvasive retinal eye examination can accurately predict the risk for chronic kidney disease (CKD) before symptoms appear, according to a retrospective study published...
AI-Powered Retinal Exam Can Predict Chronic Kidney Disease Risk
AZoRobotics | July 6, 2023 Chronic kidney disease (CKD) can be accurately predicted even before symptoms appear using an artificial intelligence (AI) algorithm combined with a non-invasive retinal eye examination, according to a study just published in Nature Partner...
MEDIWHALE WINS ASTRAZENECA’S CKD CHALLENGE FOR INNOVATIVE AI DIAGNOSTIC SOLUTION USING RETINA
Journal of Cyber Policy | June 21, 2023 "Thanks to initiatives like the CKD challenge, we achieve synergies with the entrepreneurial ecosystem, allowing us to unlock the full potential of digital health and improve the lives” — Dr. César Velasco, Director of...
Mediwhale selected for the MedTech Accelerator program
Hospital & Healthcare Management | March 22, 2023 Mediwhale, the AI-empowered health diagnostics company that uses retina scans to diagnose future cardiac and kidney disorder risk quickly and easily, will be heading to the US this month to enter the highly...